Topics
Glioblastoma | Outcomes | Tumor Treating Fields
Home > Publications > Topics > Glioblastoma > Outcomes > Tumor Treating Fields
*Kanamori M, Tsuzuki S, Shibahara I, Saito K, Shimoda Y, Tanaka K,
Yamaguchi S, Natsumeda M, Matsutani T, Hanihara M, Nakada M,
Kuroda JI, Matsuda M, Yoshimoto K, Yonezawa U, Sonoda Y, Takano K,
Yonezawa H, Otani Y, Nakahara Y, Uchida M, Nonaka M, Mineharu Y,
Kitamura Y, Yamashita S, Yamauchi T, Miyake Y, Deguchi S, Beppu T,
Tamura K, Koizumi S, Hirose Y, Asano K, Hiruta R, Kinoshita M,
Miyake K, Nakayama N, Inoue A, Ono T, Sasaki T, Akiyama Y, Fukami
S, Yoshino A, Kawanishi Y, Asanome T, Yamaguchi T, Takahashi M,
Yamasaki F, Arakawa Y, Narita Y.
Impact
of tumor-treating fields on the survival of Japanese patients
with newly diagnosed glioblastoma: A
multicenter, retrospective cohort study.
Neurooncol
Adv. 2024 Nov 28;6(1):vdae176. doi:
10.1093/noajnl/vdae176. PMID:
39659832. Observational study. ˍ